Skip to main content

Advertisement

SpringerLink
Log in

Gemeinsam mit dem Patienten klug entscheiden

Choosing wisely together with the patient

  • Schwerpunkt: Klug entscheiden
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Im Rahmen der Klug-entscheiden-Initiative der Deutschen Gesellschaft für Innere Medizin (DGIM) wurden die mit der Inneren Medizin assoziierten Fachgesellschaften gebeten, aus den jeweils 60 definierten Beispielen der Über- und Unterversorgung diejenigen zu benennen und hervorzuheben, die für die direkte Arzt-Patienten-Interaktion von unmittelbarer Relevanz sind. Dabei sind von den zwölf Fachgesellschaften jeweils zwei Empfehlungen erarbeitet und begründet worden. Somit ergibt sich ein Spektrum wichtiger Empfehlungen, das die gesamte Innere Medizin umfasst. Es soll dazu beitragen, das Gespräch mit dem Patienten in schwierigen Situationen auf wissenschaftlich gesicherte Erkenntnisse auszurichten.

Abstract

Within the framework of the Choosing wisely initiative of the German Society for Internal Medicine, all scientific societies associated with internal medicine were requested to highlight the unnecessary or underused medical tests or procedures out of the 60 defined examples, which are of immediate relevance within the doctor-patient interaction. Each of the 12 scientific internal medicine societies compiled and substantiated 2 recommendations. This resulted in a spectrum of important recommendations covering the entire field of internal medicine. In difficult situations these recommendations should contribute to developing and supporting the dialogue with patients on an evidence-based level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Hasenfuß G, Fölsch UR (2016) Historie, Grundlagen und Mitgliederbefragung zu „Klug entscheiden“. Internist. doi:10.1007/s00108-016-0062-6

    Google Scholar 

  2. Jung N, Berner R, Bogner J et al (2016) Klug entscheiden in der Infektiologie. Dtsch Ärztebl 113(13):510

    Google Scholar 

  3. Feldkamp J, Schott M, Gogol M et al (2016) Empfehlungen der Deutschen Gesellschaft für Endokrinologie und der Deutschen Gesellschaft für Geriatrie. Internist. DOI 10.1007/s00108-016-0072-4

    PubMed  Google Scholar 

  4. Morden NE, Colla CH, Sequist TD et al (2014) Choosing wisely – the politics and economics of labelling low-value services. N Engl J Med 370:589–592

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wolfson D, Santana J, Slass L (2014) Engaging physicians and consumers in conversations about treatment overuse and waste: a short history of the choosing wisely campaign. Acad Med 89:990–995

    Article  PubMed  Google Scholar 

  6. http://www.choosingwisely.org. Zugegriffen: 5.4.2016

  7. Guirguis-Blake JM, Beil TL, Senger CA, Whitlock EP (2014) Ultrasonography Screening for Abdominal Aortic Aneurysms: A Systematic Evidence Review for the U.S. Preventive ServicesTask Force. Ann Intern Med 160:321–329

    Article  PubMed  Google Scholar 

  8. Dabare D, Lo TTH, McCormack DJ, Kung VWS (2012) What is the role of screening in the management of abdominal aortic aneurysms? Interact Cardiovasc Thorac Surg 14:399–405

    Article  PubMed  PubMed Central  Google Scholar 

  9. Eckstein HH, Böckler D, Flessenkämper I, Schmitz-Rixen T, Debus S, Lang W (2009) Ultraschall-Screening abdominaler Aortenaneurysmen. Dtsch Arztebl Int 106(41):657–663. doi:10.3238/arztebl.2009.0657

    PubMed  PubMed Central  Google Scholar 

  10. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Ultraschall-Screening auf Bauchaortenaneurysmen. IQWiG-Berichte – Nr. 294.

  11. Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15(3):175–179

    Article  CAS  PubMed  Google Scholar 

  12. Lunt M, O’Neill TW, Felsenberg D, Reeve J, Kanis JA, Cooper C et al (2003) Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS). Bone 33(4):505–513

    Article  PubMed  Google Scholar 

  13. Reeve J, Lunt M, Felsenberg D, Silman AJ, Scheidt-Nave C, Poor G et al (2003) European Prospective Osteoporosis Study Group. Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 18(9):1664–1673

    Article  CAS  PubMed  Google Scholar 

  14. Cauley JA, Hochberg MC, Lui LY, Palermo L, Ensrud KE, Hillier TA et al (2007) Long-term risk of incident vertebral fractures. JAMA 298(23):2761–2767

    Article  CAS  PubMed  Google Scholar 

  15. Colon-Emeric C, Kuchibhatla M, Pieper C, Hawkes W, Fredman L, Magaziner J et al (2003) The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int 14(11):879–883

    Article  PubMed  Google Scholar 

  16. Prophylaxe, Diagnostik und Therapie der Osteoprose bei Männern ab dem 60. Lebensjahr und bei postmenopausalen Frauen. S3-Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e. V.

  17. Deakin T, McShane CE, Cade JE, Williams RD (2005) Group based training for self-management strategies in people with type 2 diabetes mellitus. http://www.ncbi.nlm.nih.gov/pubmed/15846663. Zugegriffen: 21.10.2015

    Book  Google Scholar 

  18. Mühlhauser I, Berger M (2002) Patient education – evaluation of a complex intervention. http://www.ncbi.nlm.nih.gov/pubmed/12488964. Zugegriffen: 21.10.2015

    Google Scholar 

  19. Duke SA, Colagiuri S, Colagiuri R (2009) Individual patient education for people with type 2 diabetes mellitus. http://www.ncbi.nlm.nih.gov/pubmed/19160249. Zugegriffen: 21.10.2015

    Book  Google Scholar 

  20. Nationale Versorgungsleitlinie Diabetes: Strukturierte Schulungsprogramme, Langfassung 1. Auflage, Version 3, Dezember 2012, Zuletzt geändert: Juni 2013 AWMF-Reg.-Nr.: nvl/001 f.

  21. Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, Pane F, Radich JP, Rousselot P, Saglio G, Saußele S, Schiffer C, Silver R, Simonsson B, Steegmann JL, Goldman JM, Hehlmann R (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood 2013(122):872–884

    Article  CAS  Google Scholar 

  22. Shaw A, Kim D, Nakagawa K, Seto T, Crinó L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O’Byrne KJ, Moro-Sibilot D, Camidge DR, Mok T, Hirsh V, Riely GJ, Iyer S, Tassell V, Polli A, Wilner KD, Jänne PA (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368(25):2385–2394

    Article  CAS  PubMed  Google Scholar 

  23. Chapman P, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O’Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA, BRIM-3 Study Group (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364(26):2507–2516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Allegra C, Jessup J, Somerfield M, Hamilton SR, Hammond EH, Hayes DF, McAllister PK, Morton RF, Schilsky RL (2009) American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 27(12):2091–2096

    Article  PubMed  Google Scholar 

  25. Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Czuczman MS, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Saad AA, Sokol L, Swinnen LJ, Tsien C, Vose JM, Wilson L, Yahalom J, Zafar N, Dwyer M, Sundar H (2015) National comprehension cancer network. Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1. J Natl Compr Canc Netw 2015(13):326–362

    Google Scholar 

  26. Bödeker et al (2015) Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health 15:1–10

    Article  Google Scholar 

  27. Uyeki TM (2014) Preventing and controlling influenza with available interventions. N Engl J Med 370:789–791

    Article  CAS  PubMed  Google Scholar 

  28. Ständigen Impfkommission (STIKO) am Robert Koch-Institut (2015) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol Bull 34:327–362

    Google Scholar 

  29. https://influenza.rki.de/Wochenberichte/2015_2016/2015-41.pdf. Zugegriffen: 18. Okt. 2015

  30. https://www.flunewseurope.org/. Zugegriffen: 18. Okt. 2015

  31. www.impfen-info.de. Zugegriffen: 18. Okt. 2015

  32. Bundesärztekammer (2011) Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung. Dtsch Arztebl 108(A):346–348

    Google Scholar 

  33. Janssens U, Burchardi H, Duttke G et al Therapiezieländerung und Therapiebegrenzung in der Intensivmedizin. Positionspapier der Sektion Ethik der DIVI. http://www.divi.de/empfehlungen/therapiezielbegrenzung/190-therapieziel%C3%A4nderung.html. Zugegriffen: 28.9.2015

    Google Scholar 

  34. Bosslet GT, Pope TM, Rubenfeld GD et al (2015) An official ATS/AACN/ACCP/ESICM/SCCM policy statement: responding to requests for potentially inappropriate treatments in intensive care units. Am J Respir Crit Care Med 191:1318–1330

    Article  PubMed  Google Scholar 

  35. Sposato LA, Cipriano LE, Saposnik G, Ruíz Vargas E, Riccio PM, Hachinski V (2015) Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 14(4):377–387

    Article  PubMed  Google Scholar 

  36. Hart RG, Pearce LA, Aguilar MI (2007) Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Ann Intern Med 147(8):590

    Article  PubMed  Google Scholar 

  37. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2012) ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719–47

  38. Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP (2014) Real-world‘ antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Am J Med 127(6):519–529

    Article  PubMed  Google Scholar 

  39. Hug JI, Clair C, Hug B, Rodondi N, Waeber G, Cornuz J, Aujesky D (2012) Risk of falls and major bleeds in patients on oral anticoagulation therapy. Am J Med 125(8):773–778

    Article  PubMed  Google Scholar 

  40. Kauz A, Pahari D (2004) The value of vaccination in chronic kidney disease. Semin Dial 17:9–11

    Article  Google Scholar 

  41. http://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/Impfempfehlungen_node.html. Zugegriffen: 25.2.2016

  42. https://www.kidney.org/atoz/content/vaccinations Zugegriffen: 25.2.2016

  43. http://www.cdc.gov/vaccines/ Zugegriffen 25.2.2016

  44. http://www.kdigo.org/pdf/KDIGO_TX_NephsTool.pdf. Zugegriffen 25.2.2016

  45. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Langversion 1.0, 2015, AWMF-Registernummer: 128/001OL, http://www.awmf.org/uploads/tx_szleitlinien/128-001OLl_S3_Palliativmedizin_2015-07.pdf. Zugegriffen: 29. August 2015 [Empfehlung 9.19; QI 9].

  46. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Langversion 1.0, 2015, AWMF-Registernummer: 128/001OL, http://www.awmf.org/uploads/tx_szleitlinien/128-001OLl_S3_Palliativmedizin_2015-07.pdf. Zugegriffen: 29. August 2015 [S3 LL Empfehlung 9.20; QI 9, Choosing wisely Canadian Society of Palliative Care 2014].

  47. http://www.choosingwiselycanada.org/wp-content/uploads/2014/09/Palliative-care-EN.pdf. Zugegriffen: 29.8.2015

  48. Andreas S, Batra A, Behr J, Chenot JF, Gillissen A, Hering T, Herth FJF, Kreuter M, Meierjürgen R, Mühlig S, Nowak D, Pfeifer M, Raupach T, Schultz K, Sitter H, Walther JW, Worth H (2014) Tabakentwöhnung bei COPD. S3-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 68:237–258

  49. Jimenez-Ruiz CA, Andreas S, Lewis KE et al (2015) Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J 46:61–79

    Article  PubMed  Google Scholar 

  50. Anthonisen NR, Skeans MA, Wise RA et al (2005) The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142:233–239

    Article  PubMed  Google Scholar 

  51. Paone G, Serpilli M, Girardi E, Conti V, Principe R, Puglisi G, De Marchis L, Schmid G (2008) The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate. J Rehabil Med 40:672–677. doi:10.2340/16501977-0234

    Article  PubMed  Google Scholar 

  52. Preiss JC, Bokemeyer B, Buhr HJ, Dignass A, Hauser W, Hartmann F et al (2014) Updated German clinical practice guideline on “Diagnosis and treatment of Crohn’s disease” 2014. Z Gastroenterol 52(12):1431–1484

    Article  CAS  PubMed  Google Scholar 

  53. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S (2006) Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 81(11):1462–1471

    Article  PubMed  Google Scholar 

  54. Timmer A, Sutherland LR, Martin F (1998) Oral contraceptive use and smoking are risk factors for relapse in Crohn’s disease. the canadian Mesalamine for remission of Crohn’s disease study group. Gastroenterology 114(6):1143–1150

    Article  CAS  PubMed  Google Scholar 

  55. Kane SV, Flicker M, Katz-Nelson F (2005) Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. J Clin Gastroenterol 39(1):32–35

    PubMed  Google Scholar 

  56. Johnson GJ, Cosnes J, Mansfield JC (2005) Review article: smoking cessation as primary therapy to modify the course of Crohn’s disease. Aliment Pharmacol Ther 21(8):921–931

    Article  CAS  PubMed  Google Scholar 

  57. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP (1996) Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterol 110(2):424–431

    Article  CAS  Google Scholar 

  58. Andreas S, Batra A, Behr J, Chenot JF, Gillissen A, Hering T et al (2014) Smoking cessation in patients with COPD. Pneumol 68(4):237–258

    Article  CAS  Google Scholar 

  59. Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK), AWMF-Register-Nr. 065/003.

  60. Cao P, Eckstein HH, De Rango P et al (2011) Critical limb ischemia. Chapter II: Diagnostic Methods. Eur J Vasc Endovascular Surg 42(S2):S13–S32

    Article  Google Scholar 

  61. Chan D, Anderson ME, Dolmatch BL (2010) Imaging evaluation of lower extremity infrainguinal disease: role of the noninvasive vascular laboratory, computed tomography angiography, and magnetic resonance angiography. Tech Vasc Interv Radiol 13:11–22

    Article  PubMed  Google Scholar 

  62. Finucane TE, Christmas C, Travis K (1999) Tube feeding in patients with advanced dementia: a review of the evidence. JAMA 282:1365–1370

    Article  CAS  PubMed  Google Scholar 

  63. Gabriel SE, Normand ST (2012) Getting the methods right – the foundation of patient-centered outcomes research. N Engl J Med 367:787–790

    Article  CAS  PubMed  Google Scholar 

  64. Teno JM, Feng Z, Mitchell SL, Kuo S, Intrator O, Mor V (2008) Do financial incentives of introducing case mix reimbursement increase feeding tube use in nursing home residents? J Am Geriatr Soc 56:887–890

    Article  PubMed  PubMed Central  Google Scholar 

  65. Teno JM, Mitchell SL, Kuo SK, Gozalo PL, Rhodes RL et al (2011) Decision-making and outcomes of feeding tube insertion: a five-state study. J Am Geriatr Soc 59:881–886

    Article  PubMed  PubMed Central  Google Scholar 

  66. Palecek EJ, Teno JM, Casarett DJ, Hanson LC, Rhodes RL, Mitchell SL (2010) Comfort feeding only: a proposal to bring clarity to decision-making regarding difficulty with eating for persons with advanced dementia. J Am Geriatr Soc 58:580–584

    Article  PubMed  PubMed Central  Google Scholar 

  67. Hanson LC, Carey TS, Caprio AJ, Lee TJ, Ersek M et al (2011) Improving decision-making for feeding options in advanced dementia: a randomized, controlled trial. J Am Geriatr Soc 59:2009–2016

    Article  PubMed  PubMed Central  Google Scholar 

  68. Teno JM, Gozalo PL, Mitchell SL, Kuo S, Rhodes RL et al (2012) Does feeding tube insertion and its timing improve survival? J Am Geriatr Soc 60:1918–1921

    Article  PubMed  PubMed Central  Google Scholar 

  69. Hanson LC, Ersek M, Gilliam R, Carey TS (2011) Oral feeding options for people with dementia: a systematic review. J Am Geriatr Soc 59:463–472

    Article  PubMed  PubMed Central  Google Scholar 

  70. Sorrell JM (2010) Use of feeding tubes in patients with advanced dementia: are we doing harm? J Psychosoc Nurs Ment Health Serv 48:15–18

    Google Scholar 

  71. Sampson EL, Candy B, Jones L (2009) Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev 2:CD007209

    PubMed  Google Scholar 

  72. Gillick MR, Volandes AE (2008) The standard of caring: why do we still use feeding tubes in patients with advanced dementia? J Am Med Dir Assoc 9:364–367

    Article  PubMed  Google Scholar 

  73. Ganzini L (2006) Artificial nutrition and hydration at the end of life: ethics and evidence. Palliat Support Care 4:135–143

    Article  PubMed  Google Scholar 

  74. Li I (2002) Feeding tubes in patients with severe dementia. Am Fam Physician 65:1605–1611

    PubMed  Google Scholar 

  75. Mitchell SL, Kiely DK, Lipsitz LA (1997) The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Arch Intern Med 157:327–332

    Article  CAS  PubMed  Google Scholar 

  76. Finkle WD, Der JS, Greenland S, Adams JL, Ridgeway G et al (2011) Risk of fractures requiring hospitalization after an initial prescription of zolpidem, alprazolam, lorazepam or diazepam in older adults. J Am Geriatr Soc 59:1883–1890

    Article  PubMed  Google Scholar 

  77. Allain H, Bentue-Ferrer D, Polard E, Akwa Y, Patat A (2005) Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging 22:749–765

    Article  PubMed  Google Scholar 

  78. American Geriatrics Society (2015) Beers criteria update expert panel. american geriatrics society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. doi:10.1111/jgs.13702

    Google Scholar 

  79. Kripke DF, Langer RD, Kline LE (2012) Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ 2:e000850

    Google Scholar 

  80. Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331:1169

    Article  PubMed  PubMed Central  Google Scholar 

  81. Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE et al (2006) Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 295:2851–2858

    Article  PubMed  Google Scholar 

  82. Hanlon JT, Semla TP, Schmader KE (2015) Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc. doi:10.1111/jgs.13807

    Google Scholar 

  83. Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367:1616–1625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N (2003) A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 327:195–198

    Article  PubMed  PubMed Central  Google Scholar 

  85. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315–321

    Article  PubMed  Google Scholar 

  86. Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, Neugut AI, Maciejewski PK (2015) Chemotherapy Use, Performance Status, and Quality of Life at the End of Life. JAMA Oncol 1:778–784

    Article  PubMed  Google Scholar 

  87. Azzoli CG, Temin S, Aliff T et al (2011) 2011 focused update of 2009 American Society of Oncology clinical practice guideline update on chemotherapy for stage IV non-small cell lung cance. J Clin Oncol 29:3825–3831

    Article  PubMed  PubMed Central  Google Scholar 

  88. Ettinger DS, Akerley W, Bepler G et al (2010) Non-small cell lung cancer. J Natl Compr Canc Netw 8:740–801

    CAS  PubMed  Google Scholar 

  89. Carlson RW, Allred DC, Anderson BO et al (2009) Breast cancer. J Natl Compr Canc Netw 7:122–192

    CAS  PubMed  Google Scholar 

  90. Engstrom PF, Benson AB 3rd, Chen YJ et al (2005) Colon cancer clinical practice guidelines. J Natl Compr Canc Netw 3:468–491

    PubMed  Google Scholar 

  91. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Langversion 1.0, 2015, AWMF-Registernummer: 128/001OL, http://www.awmf.org/uploads/tx_szleitlinien/128-001OLl_S3_Palliativmedizin_2015-07.pdf. Zugegriffen: 29.8.2015.

  92. Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721–1730

    Article  PubMed  Google Scholar 

  93. Gaertner J, Wolf J, Voltz R (2012) Early palliative care for patients with metastatic cancer. Curr Opin Oncol 24:357–362

    Article  PubMed  Google Scholar 

  94. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742

    Article  CAS  PubMed  Google Scholar 

  95. Shapiro DJ et al (2014) Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. J Antimicrob Chemother 69:234–240

    Article  CAS  PubMed  Google Scholar 

  96. Barnett ML, Linder JA (2014) Antibiotic prescribing for adults with acute bronchitis in the United States, 1996–2010. JAMA 311:2020–2022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Little P et al (2013) Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 13:123–129

    Article  CAS  PubMed  Google Scholar 

  98. Hersh AL, American Academy of Pediatrics Committee on Infectious Diseases. (2013) Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics 132:1146–1154

    Article  PubMed  Google Scholar 

  99. S3 Leitlinie DEGAM-Nr. 11. Husten (2014).

  100. Dellinger RP, Levy MM, Rhodes A et al (2012) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2013(41):580–637

    Google Scholar 

  101. Jong E de, Oers JA van, Beishuizen A et al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label tria. http://thelancet.com/pdfs/journals/laninf/PIIS1473-3099(16)00053-0.pdf. Zugegriffen: 11.3.2016

    Google Scholar 

  102. Stone GW, Parise H, Witzenbichler B, Kirtane A, Guagliumi G et al (2010) Selection criteria for drug versus bare-metal stents and the impact of routine angiographic follow-up: 2‑year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 56:1597–1604

    Article  CAS  PubMed  Google Scholar 

  103. Pinto DS, Stone GW, Ellis SG, Cox DA et al (2006) Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting Stents. Results from the TAXUS-IV Trial. J Am Coll Cardiol 48:32–36

    Article  PubMed  Google Scholar 

  104. Uchida T, Popma J, Stone GW et al (2010) The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of “oculostenotic” reintervention in patients with intermediate lesions. JACC Cardiovasc Interv 3:403–411

    Article  PubMed  Google Scholar 

  105. Cassese S, Byrne RA, Schulz S, Hoppman P et al (2015) Prognostic role of restenosis in 10004 patients undergoing routine control angiography after coronary stenting. Eur Heart J 36:94–99

    Article  PubMed  Google Scholar 

  106. Bonzel T, Hamm CW, Albrecht A, Erbel R, Kelm M, Lange H, Levenson B, Neumann FJ, Rupprecht HJ, Schächinger V, Terres W, Voelker W, Zahn R (2009) Leitfaden Herzkatheter. Steinkopff, Darmstadt

    Book  Google Scholar 

  107. Rassaf T, Steiner S, Kelm M (2013) Postoperative care and Follow-Up After Coronary Stenting. Dtsch Arztebl Int 110(5):72–82

    PubMed  PubMed Central  Google Scholar 

  108. Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541–2619.

  109. Levine GN, Bates ER, Blankenship JC, Bailey SR et al (2011) 2011 ACCF/AHA/SCAI guideline for Percutaneous coronary intervention: a report of the american college of cardiology foundation/american heart association task force on practice guidelines and the society for cardiovascular Angiography and interventions. Circulation 124:e574–e651

    Article  PubMed  Google Scholar 

  110. Palmer SC, Wong G, Iff S, Yang J, Jayaswal V, Craig JC, Rochtchina E, Mitchell P, Wang JJ, Strippoli GF (2014) Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: a population-based longitudinal cohort study. Nephrol Dial Transplant 29(7):1377–1384

    Article  PubMed  Google Scholar 

  111. Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD (2011) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 6(5):966–967

    Article  PubMed  PubMed Central  Google Scholar 

  112. Payen D, Pont AC de, Sakr Y, Spies C, Reinhart K, Vincent JL (2008) Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 12(3):R74

    Article  PubMed  PubMed Central  Google Scholar 

  113. Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL (2009) Program to improve care in acute renal disease (PICARD) study group. fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76(4):422

    Article  PubMed  Google Scholar 

  114. Schnipper LE, Smith TJ, Raghavan D, Blayney DW, Ganz PA, Mulvey TM, Wollinset DA (2012) American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology. J Clin Oncol 30(14):1715–1724

    Article  PubMed  Google Scholar 

  115. Bundesärztekammer (2011) Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung Präambel. Dtsch Arztebl 108(7):A346–A348

    Google Scholar 

  116. Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409

    Article  PubMed  Google Scholar 

  117. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307(22):2418–2429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli I, Bertolotti R, Spaggiari L (2012) Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med 157(11):776–784

    Article  PubMed  Google Scholar 

  119. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG (2013) Screening for lung cancer with low-dose computed tomography: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 159(6):411–420

    Article  PubMed  Google Scholar 

  120. Herth FJF, Hoffmann H, Heussel CP (2014) Lungenkrebs-Screening – Update 2014. Pneumologie 68:781–783

    Article  CAS  PubMed  Google Scholar 

  121. Nationale Versorgungsleitlinie (NVL) Kreuzschmerz, Kurzfassung, Version 1.2.

  122. Auwarter PG, Bakken JS, Dattwyler RS et al (2011) Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis 11:713–719

    Article  Google Scholar 

  123. Stanek G, Fingerle V, Hunfeld KP et al (2011) Lyme borreliosis: clinical case definitions for diagnosis and management in Europe (European Union Concerted Action on LB). Clin Microbiol Infect 17:69–79

    Article  CAS  PubMed  Google Scholar 

  124. Sigal LH (2011) Musculoskeletal features of Lyme disease: understanding the pathogenesis of clinical findings helps make appropriate therapeutic choices. J Clin Rheumatol 17:256–265

    Article  PubMed  Google Scholar 

  125. Feder HM, Johnson BJB, O’Connell S et al (2007) A critical appraisal of “Chronic Lyme Disease”. N Engl J med 357:1422–1430

    Article  CAS  PubMed  Google Scholar 

  126. Preiß JC, Bokemeyer B, Buhr HJ et al (2014) Aktualisierte S3-Leitlinie Diagnostik und Therapie des Morbus Crohn. Z Gastroenterol 52:1431–1484

  127. Dignass A, Preiß JC, Aust DE et al (2011) Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa. Z Gastroenterol 49:1276–1341

  128. Steinhart AH, Ewe K, Griffiths AM et al (2003) Corticosteroids for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. doi:10.1002/14651858.CD000301

    PubMed  Google Scholar 

  129. Lindgren S, Lofberg R, Bergholm L et al (2002) Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Scand J Gastroenterol 37:705–710

    Article  CAS  PubMed  Google Scholar 

  130. Meyers S, Lerer PK, Feuer EJ et al (1987) Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol 9:50–54

    Article  CAS  PubMed  Google Scholar 

  131. Lichtenstein GR, Feagan BG, Cohen RD et al (2012) Serious infection and mortality in patients with Crohn’s disease: more than 5 years of followup in the TREAT registry. Am J Gastroenterol 107:1409–1422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Fölsch UR, Faulbaum F, Hasenfuß G (2016) Klug entscheiden - Initiative. Eine Mitgliederbefragung der Deutschen Gesellschaft für Innere Medizin. Dtsch Arztebl 113(13):604

    Google Scholar 

Download references

Danksagung

Die Benennung der hier genannten Beispiele einer Überversorgung und Unterversorgung der Patienten war nur möglich durch die Beiträge, die große Unterstützung und die Arbeit der Konsensuskommission Klug entscheiden, der wir zu sehr großem Dank verpflichtet sind.

Ein ganz besonderer Dank gilt auch der wissenschaftlichen Mitarbeiterin der Geschäftsstelle der Deutschen Gesellschaft für Innere Medizin, Frau Katja Müller, für die geduldige und kompetente Koordination und Überarbeitung der Klug-entscheiden-Empfehlungen der internistischen Fachgesellschaften.

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin 1, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Schittenhelmstr. 12, 24105, Kiel, Deutschland

    U. R. Fölsch

  2. Klinik für Kardiologie und Pneumologie, Zentrum für Innere Medizin, Georg-August-Universität Göttingen, Göttingen, Deutschland

    G. Hasenfuß

Authors
  1. U. R. Fölsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Hasenfuß
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. R. Fölsch.

Ethics declarations

Interessenkonflikt

U.R. Fölsch und G. Hasenfuß geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

M. Hallek, Köln

G. Hasenfuß, Göttingen

E. Märker-Hermann, Wiesbaden

C. Sieber, Nürnberg

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fölsch, U.R., Hasenfuß, G. Gemeinsam mit dem Patienten klug entscheiden. Internist 57, 540–550 (2016). https://doi.org/10.1007/s00108-016-0069-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-016-0069-z

Schlüsselwörter

Keywords

Search

Navigation